Drugs / COMBIVENT HFA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02194205 | Oct 2000 → Jun 2001 | chronic obstructive pulmonary disease | Boehringer Ingelheim | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COMBIVENT HFA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02194205 ↗ |
| Route | Inhaled | “COMBIVENT HFA Inhalation Aerosol” NCT02194205 ↗ |